3-86978565-T-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The ENST00000398399.7(VGLL3):​c.364A>T​(p.Ile122Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,614,162 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000024 ( 1 hom. )

Consequence

VGLL3
ENST00000398399.7 missense

Scores

5
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.95
Variant links:
Genes affected
VGLL3 (HGNC:24327): (vestigial like family member 3) Predicted to enable protein C-terminus binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.11539909).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
VGLL3NM_016206.4 linkuse as main transcriptc.364A>T p.Ile122Phe missense_variant 2/4 ENST00000398399.7 NP_057290.2
VGLL3NM_001320493.2 linkuse as main transcriptc.364A>T p.Ile122Phe missense_variant 2/4 NP_001307422.1
VGLL3NM_001320494.2 linkuse as main transcriptc.205A>T p.Ile69Phe missense_variant 2/4 NP_001307423.1
VGLL3XM_006713138.5 linkuse as main transcriptc.361A>T p.Ile121Phe missense_variant 2/4 XP_006713201.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
VGLL3ENST00000398399.7 linkuse as main transcriptc.364A>T p.Ile122Phe missense_variant 2/41 NM_016206.4 ENSP00000381436 P1A8MV65-1
VGLL3ENST00000383698.3 linkuse as main transcriptc.364A>T p.Ile122Phe missense_variant 2/41 ENSP00000373199 A8MV65-2
VGLL3ENST00000494229.1 linkuse as main transcriptc.166A>T p.Ile56Phe missense_variant 2/33 ENSP00000419115

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152196
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000482
AC:
12
AN:
249160
Hom.:
0
AF XY:
0.0000740
AC XY:
10
AN XY:
135208
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000392
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000239
AC:
35
AN:
1461848
Hom.:
1
Cov.:
31
AF XY:
0.0000358
AC XY:
26
AN XY:
727228
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000406
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152314
Hom.:
0
Cov.:
32
AF XY:
0.0000269
AC XY:
2
AN XY:
74480
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378
ExAC
AF:
0.0000662
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 20, 2024The c.364A>T (p.I122F) alteration is located in exon 2 (coding exon 2) of the VGLL3 gene. This alteration results from a A to T substitution at nucleotide position 364, causing the isoleucine (I) at amino acid position 122 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.026
T;.
Eigen
Uncertain
0.23
Eigen_PC
Uncertain
0.32
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.85
T;T
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.12
T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
1.9
M;M
MutationTaster
Benign
0.59
D;D
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
-1.1
N;N
REVEL
Benign
0.10
Sift
Benign
0.12
T;T
Sift4G
Benign
0.37
T;T
Polyphen
0.79
P;.
Vest4
0.31
MutPred
0.21
Loss of glycosylation at S125 (P = 0.0304);Loss of glycosylation at S125 (P = 0.0304);
MVP
0.30
MPC
0.38
ClinPred
0.13
T
GERP RS
5.3
Varity_R
0.083
gMVP
0.10

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs761478211; hg19: chr3-87027715; API